Skip to main content

Home Library Publishing About

Home Library Publishing About

PJ McCarthy

ID:LEX-AR-4JCBD2FJ

/

Unclaimed

/

Organization: Goodwin Procter

Sandoz’s High Concentration Adalimumab Biosimilar Application Accepted by EMA

Big Molecule Watch · June 24, 2022

Expanding Operations in Biologics

Big Molecule Watch · April 18, 2022

International Trade Commission Institutes Investigation of Alvotech’s Adalimumab Biosimilar

Big Molecule Watch · February 8, 2022

Phase 1 Clinical Trial of Aflibercept (Eylea®) Biosimilar Completed by Alteogen

Big Molecule Watch · April 2, 2021

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Copyright © 2026 LexBlog, Inc. and The Library at LexBlog, Inc. All Rights Reserved.

Privacy Policy Terms of Service